Search Amgen Russia Web resources FOR HEALTHCARE PROFESSIONALS MASS MEDIA FOR PARTNERS CAREER ABOUT COMPANY SCIENTIFIC ACTIVITY PRODUCTS RESPONSIBILITY COMPANY FACTS HOME ABOUT COMPANY COMPANY FACTS Company facts By discovering and exploring new things, developing and producing innovative drugs, Amgen is unlocking the possibilities of biology for patients suffering from serious diseases. The use of progressive methods of genetic engineering makes it possible to establish the complex pathogenesis of the disease and to understand the foundations of human biology. Amgen focuses on areas where there is a high unmet medical need, and uses its expertise in biologics to provide solutions that improve treatment outcomes and ultimately significantly improve a person's life. Amgen, one of the first biotech companies, established in 1980, today has become the world leader among independent biotech companies. More than a million patients around the world are already receiving the company's drugs, while Инновационные лекарственные препараты Лекарственные препараты Амджен используются при лечении тяжелых заболеваний. Мы присутствуем более чем в 75 странах во всем мире, и миллионы пациентов, страдающих от онкологических заболеваний, поражений костей, заболеваний почек, ревматоидного артрита и других серьезных заболеваний, получают наши препараты. Наши препараты, как правило, применяются при заболеваниях, при которых либо крайне ограничены возможности лечения, либо существует потребность в более эффективном лечении. Инновационные исследования Научно-исследовательские разработки линейки инновационных препаратов основаны на понимании фундаментальных биологических механизмов функционирования человеческого организма. Сначала Амджен определяет основные молекулярные процессы, приводящие к заболеванию, а потом определяет оптимальный тип молекулы для получения лекарственного препарата с наилучшей эффективностью и безопасностью. Современные достижения генетики человека проливают свет на молекулярные причины возникновения заболеваний, мы планируем и дальше совершенствоваться в этой области, выявляя те звенья патогенеза, которые впоследствии станут своего рода «мишенями» для лекарственных средств. Производство мирового уровня The treatment of millions of patients with serious illnesses around the world depends on the safe and reliable manufacturing of biologics. The world leader in biological manufacturing, Amgen has an exceptional track record of ensuring the smooth production and delivery of drugs to patients. A high level of professionalism, experience, reliable control and responsibility are important factors that guarantee the quality of a biological product every time a new batch is produced. For Amgen, reliable quality control and consistency of drug supply are as important as the scientific development of new drugs. ABOUT COMPANY Company facts Mission and values Amgen in Russia Partnership and support Amgen in the world History of Amgen About company Company facts Mission and values Amgen in Russia Partnership and support Amgen in the world History of Amgen Scientific activity Research strategy Product portfolio Introduction to Biotechnology Quality and reliability of production Bioanalogues Clinical researches Products For Healthcare Professionals Responsibility Amgen Foundation Environment protection Disclosure of information in the field of labor protection For healthcare professionals mass media For partners Career Be in touch Contacts © 2017 Amgen Inc. All rights reserved RU-C-0-1016-039811 Notice to Amgen about the processing of personal data Terms of Use × We use first-party and third-party cookies to collect statistical information to personalize our website for users and to ensure your user experience. If you continue without changing your settings, this means that you agree to receive any cookies from the Amgen website and to use other tracking technologies for the purposes described in our Cookie Information . Please keep in mind that you can change your cookie settings at any time by changing your browser settings.